Dupilumab-associated hypereosinophilia in severe asthma.
ERJ Open Res
; 10(4)2024 Jul.
Article
en En
| MEDLINE
| ID: mdl-39040583
ABSTRACT
Dupilumab has been associated with adverse reactions including symptomatic hypereosinophilia. This study reports the incidence of dupilumab-related eosinophilia and adverse reactions in severe asthma patients at an Australian tertiary centre. https//bit.ly/3JgZ5Ya.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
ERJ Open Res
Año:
2024
Tipo del documento:
Article
País de afiliación:
Australia